v3.26.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Concentration of Risk, by Risk Factor and Significant Payer For each significant payor and customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable are as follows:
 
 Revenue
 Three Months Ended
March 31,
 20262025
Customer A24 %23 %
Customer B21 %18 %

Accounts Receivable, Net
 March 31, 2026December 31, 2025
Customer A26 %23 %
Customer B23 %19 %
Customer C11 %14 %
Schedule of Disaggregation of Revenue
The following table includes the Company's revenues as disaggregated by payor and customer category (in thousands):
 
 Three Months Ended March 31,
 20262025
Revenue:
Commercial$9,476 $8,185 
Government4,281 3,637 
Client direct bill(1)3,450 3,600 
Other(2)99 76 
Total revenue$17,306 $15,498 
(1)Includes hospitals, other laboratories, etc.
(2)Includes patient self-pay.
Schedule of Cash and Cash Equivalents
Cash, cash equivalents and restricted cash presented in the accompanying condensed statements of cash flows consist of the following (in thousands):
 
 March 31, 2026December 31, 2025
Cash and cash equivalents$21,513 $32,220 
Restricted cash200 200 
Total cash, cash equivalents and restricted cash$21,713 $32,420 
Schedule of Restricted Cash and Cash Equivalents
Cash, cash equivalents and restricted cash presented in the accompanying condensed statements of cash flows consist of the following (in thousands):
 
 March 31, 2026December 31, 2025
Cash and cash equivalents$21,513 $32,220 
Restricted cash200 200 
Total cash, cash equivalents and restricted cash$21,713 $32,420 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows (in common stock equivalent shares):
 
 March 31, 2026March 31, 2025
Warrants to purchase common stock131 325,330 
Common stock options706,839 608,146 
Restricted stock units2,129,706 1,822,547 
Employee stock purchase plan17,480 14,844 
Total2,854,156 2,770,867